270 related articles for article (PubMed ID: 14712350)
1. Retinoic acid receptor alpha and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat.
Schaier M; Liebler S; Schade K; Shimizu F; Kawachi H; Grone HJ; Chandraratna R; Ritz E; Wagner J
J Mol Med (Berl); 2004 Feb; 82(2):116-25. PubMed ID: 14712350
[TBL] [Abstract][Full Text] [Related]
2. The renal retinoid system: time-dependent activation in experimental glomerulonephritis.
Liebler S; Uberschär B; Kübert H; Brems S; Schnitger A; Tsukada M; Zouboulis CC; Ritz E; Wagner J
Am J Physiol Renal Physiol; 2004 Mar; 286(3):F458-65. PubMed ID: 14583434
[TBL] [Abstract][Full Text] [Related]
3. Retinoid receptor-specific agonists alleviate experimental glomerulonephritis.
Lehrke I; Schaier M; Schade K; Morath C; Waldherr R; Ritz E; Wagner J
Am J Physiol Renal Physiol; 2002 Apr; 282(4):F741-51. PubMed ID: 11880336
[TBL] [Abstract][Full Text] [Related]
4. Isotretinoin alleviates renal damage in rat chronic glomerulonephritis.
Schaier M; Lehrke I; Schade K; Morath C; Shimizu F; Kawachi H; Grone HJ; Ritz E; Wagner J
Kidney Int; 2001 Dec; 60(6):2222-34. PubMed ID: 11737596
[TBL] [Abstract][Full Text] [Related]
5. Retinoid X receptor agonist elevation of serum triglycerides in rats by potentiation of retinoic acid receptor agonist induction or by action as single agents.
Standeven AM; Thacher SM; Yuan YD; Escobar M; Vuligonda V; Beard RL; Chandraratna RA
Biochem Pharmacol; 2001 Dec; 62(11):1501-9. PubMed ID: 11728386
[TBL] [Abstract][Full Text] [Related]
6. Differential modulation of rat hepatic stellate phenotype by natural and synthetic retinoids.
Hellemans K; Verbuyst P; Quartier E; Schuit F; Rombouts K; Chandraratna RA; Schuppan D; Geerts A
Hepatology; 2004 Jan; 39(1):97-108. PubMed ID: 14752828
[TBL] [Abstract][Full Text] [Related]
7. Effects of retinoids on the TGF-beta system and extracellular matrix in experimental glomerulonephritis.
Morath C; Dechow C; Lehrke I; Haxsen V; Waldherr R; Floege J; Ritz E; Wagner J
J Am Soc Nephrol; 2001 Nov; 12(11):2300-2309. PubMed ID: 11675406
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of the inducible NO synthase activation by retinoic acid is mimicked by RARalpha agonist in vivo.
Seguin-Devaux C; Devaux Y; Latger-Cannard V; Grosjean S; Rochette-Egly C; Zannad F; Meistelman C; Mertes PM; Longrois D
Am J Physiol Endocrinol Metab; 2002 Sep; 283(3):E525-35. PubMed ID: 12169446
[TBL] [Abstract][Full Text] [Related]
9. Retinoids inhibit the actions of angiotensin II on vascular smooth muscle cells.
Haxsen V; Adam-Stitah S; Ritz E; Wagner J
Circ Res; 2001 Mar; 88(6):637-44. PubMed ID: 11282899
[TBL] [Abstract][Full Text] [Related]
10. Nuclear (receptor) power: retinoids in rat mesangioproliferative disease.
Wagner J
Nephrol Dial Transplant; 2002; 17 Suppl 9():81-3. PubMed ID: 12386299
[TBL] [Abstract][Full Text] [Related]
11. Synergistic teratogenic effects induced by retinoids in mice by coadministration of a RARalpha- or RARgamma-selective agonist with a RXR-selective agonist.
Elmazar MM; Rühl R; Nau H
Toxicol Appl Pharmacol; 2001 Jan; 170(1):2-9. PubMed ID: 11141350
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid reduces glomerular injury in a rat model of glomerular damage.
Wagner J; Dechow C; Morath C; Lehrke I; Amann K; Waldherr R; Floege J; Ritz E
J Am Soc Nephrol; 2000 Aug; 11(8):1479-1487. PubMed ID: 10906161
[TBL] [Abstract][Full Text] [Related]
13. Benidipine, a long-acting calcium-channel blocker, prevents the progression to end-stage renal failure in a rat mesangioproliferative glomerulonephritis.
Nakamura T; Obata JE; Onitsuka M; Shimada Y; Yoshida Y; Kawachi H; Shimizu F
Nephron; 2000 Nov; 86(3):315-26. PubMed ID: 11096289
[TBL] [Abstract][Full Text] [Related]
14. Mitogenic effect of retinoid X receptor agonists in rat liver.
Standeven AM; Escobar M; Beard RL; Yuan YD; Chandraratna RA
Biochem Pharmacol; 1997 Aug; 54(4):517-24. PubMed ID: 9313779
[TBL] [Abstract][Full Text] [Related]
15. Keratins 2 and 4/13 in reconstituted human skin are reciprocally regulated by retinoids binding to nuclear receptor RARalpha.
Virtanen M; Sirsjö A; Vahlquist A; Törmä H
Exp Dermatol; 2010 Jul; 19(7):674-81. PubMed ID: 20456496
[TBL] [Abstract][Full Text] [Related]
16. Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms.
Villa L; Boor P; Konieczny A; Kunter U; van Roeyen CR; Denecke B; Gan L; Neusser MA; Cohen CD; ; Eitner F; Scholl T; Ostendorf T; Floege J
J Pathol; 2013 Apr; 229(5):672-84. PubMed ID: 23192593
[TBL] [Abstract][Full Text] [Related]
17. Retinoid signalling and gene expression in neuroblastoma cells: RXR agonist and antagonist effects on CRABP-II and RARbeta expression.
Hewson QC; Lovat PE; Pearson AD; Redfern CP
J Cell Biochem; 2002; 87(3):284-91. PubMed ID: 12397610
[TBL] [Abstract][Full Text] [Related]
18. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of the teratogenic effects induced by coadministration of retinoic acid or phytanic acid/phytol with synthetic retinoid receptor ligands.
Elmazar MM; Nau H
Arch Toxicol; 2004 Nov; 78(11):660-8. PubMed ID: 15558240
[TBL] [Abstract][Full Text] [Related]
20. Cooperative therapeutic action of retinoic acid receptor and retinoid x receptor agonists in a mouse model of Alzheimer's disease.
Kawahara K; Suenobu M; Ohtsuka H; Kuniyasu A; Sugimoto Y; Nakagomi M; Fukasawa H; Shudo K; Nakayama H
J Alzheimers Dis; 2014; 42(2):587-605. PubMed ID: 24916544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]